Insider screener

Period: 12 months Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

46,134 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

46,134 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

46,134 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

46,134 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
46,134 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
46,134 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

46,134 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
9 Feb 2026
Sold on a plan
$33.92K 1,000 at 33.92
4.5%
Planned (10b5-1)
9 Feb 2026
SHERIFF WILLIAM M See Remarks
Sold on a plan
$33.60K 12,000 at 2.80
0.5%
Planned (10b5-1)
9 Feb 2026
GOLSEN BARRY H Director · indirect
Sold on a plan 2×
$33.21K 3,321 at 10.00
9.3%
Planned (10b5-1)
9 Feb 2026
SUEN JACOB President and CEO
Sold on a plan
$30.60K 6,112 at 5.01
2.1%
Planned (10b5-1)
9 Feb 2026
Francis Chris See Remarks
Sold at will
$25.33K 1,883 at 13.45
3.0%
Not planned
9 Feb 2026
Meltzer Jonathan C EVP, Operations
Sold on a plan
$24.25K 88 at 275.53
3.0%
Planned (10b5-1)
9 Feb 2026
WIRTJES SEAN M CHIEF FINANCIAL OFFICER
Sold at will
$22.80K 6,027 at 3.78
1.2%
Not planned
9 Feb 2026
Sold on a plan
$19.80K 100 at 198.00
3.3%
Planned (10b5-1)
9 Feb 2026
Wilson John J. Addington CHIEF OPERATING OFFICER
Sold at will
$17.44K 4,610 at 3.78
1.8%
Not planned
9 Feb 2026
Abel Robert Lorne See Remarks
Sold on a plan
$16.62K 1,230 at 13.51
6.0%
Planned (10b5-1)
9 Feb 2026
Fusaro Angelo G Principal Accounting Officer
Sold at will
$15.76K 316 at 49.88
12.2%
Not planned
9 Feb 2026
Sadri Ali Chief Technology Officer
Sold on a plan
$10.62K 2,119 at 5.01
1.7%
Planned (10b5-1)
9 Feb 2026
Bos Teresa D. 10% owner
Sold at will
$9.27K 662 at 14.01
0.1%
Not planned
9 Feb 2026
Vultaggio Vincent PAO and PFO
Sold on a plan
$8.09K 3,379 at 2.39
2.2%
Planned (10b5-1)
9 Feb 2026
EASTLAND JULIA MARIE CEO & President
Sold at will
$2.13K 889 at 2.39
1.1%
Not planned
9 Feb 2026
MAROONE MICHAEL E Director · indirect
Sold at will
$1.23K 3 at 411.61
1.1%
Not planned
9 Feb 2026
Bruns Ingmar Chief Medical Officer
Sold at will
$801.62 335 at 2.39
1.0%
Not planned
6 Feb 2026
Sold at will
$64.32M 54,923 at 1,171.16
5.3%
Not planned
6 Feb 2026
HAAS ALESIA J Chief Financial Officer
Sold on a plan 6×
$56.50M 364,600 at 154.95
47.6%
Planned (10b5-1)
6 Feb 2026
Phillips Jason President
Sold at will
$30.89M 100,000 at 308.92
88.8%
Sold half or more
6 Feb 2026
Xiao Deming EVP, Global Operations
Sold at will
$26.79M 22,875 at 1,171.16
8.8%
Not planned
6 Feb 2026
Tseng Saria EVP & General Counsel
Sold at will
$26.79M 22,875 at 1,171.16
10.2%
Not planned
6 Feb 2026
Sciammas Maurice EVP, WW Sales & Marketing
Sold at will
$26.79M 22,875 at 1,171.16
11.4%
Not planned
6 Feb 2026
BLEGEN THEODORE EVP and CFO
Sold at will
$25.44M 21,725 at 1,171.16
20.9%
Not planned
6 Feb 2026
OCAMPO SUSAN 10% owner · indirect
Sold at will
$23.58M 100,000 at 235.85
2.3%
Not planned
6 Feb 2026
HAUENSTEIN GLEN W President
Sold at will 2×
$21.04M 289,774 at 72.61
41.0%
Not planned
6 Feb 2026
GALLAGHER MAURICE J JR Executive Chairman
Sold at will 2×
$19.99M 175,000 at 114.23
8.2%
Not planned
6 Feb 2026
De Lange Bob Group President
Sold at will
$16.31M 22,656 at 720.11
22.1%
Not planned
6 Feb 2026
Warden Kathy J Chair, CEO and President
Sold at will 7×
$14.18M 20,000 at 708.82
10.4%
Not planned
6 Feb 2026
BAKKER GERBEN Chairman, President & CEO
Sold at will 11×
$12.59M 25,233 at 498.97
28.1%
Not planned
6 Feb 2026
Sold at will
$10.80M 303,200 at 35.62
1.0%
Not planned
6 Feb 2026
Saligram Girish President and CEO · indirect
Sold at will 2×
$10.55M 100,000 at 105.50
100%
Sold half or more
6 Feb 2026
BOROUGHS TIMOTHY ALAN Executive Vice President*
Sold at will 2×
$9.23M 27,817 at 331.98
70.2%
Sold half or more
6 Feb 2026
Speiser Michael L Director · indirect
Sold on a plan 12×
$8.32M 50,338 at 165.22
61.8%
Sold half or more
6 Feb 2026
BRANDT ERIC Director
Sold at will 2×
$7.90M 35,000 at 225.60
12.1%
Not planned
6 Feb 2026
Bettinger Walter W Co-Chairman · indirect
Sold at will
$7.04M 67,514 at 104.25
11.3%
Not planned
6 Feb 2026
Sold at will
$5.54M 195,297 at 28.39
5.7%
Not planned
6 Feb 2026
Murphy Robert C. Chief Technology Officer
Sold on a plan
$5.27M 1,000,000 at 5.27
1.9%
Planned (10b5-1)
6 Feb 2026
Lawler Mary Katherine SVP & Chief HR Officer
Sold at will
$5.04M 17,279 at 291.90
37.5%
Not planned
6 Feb 2026
Lu James Fu Bin 10% owner · indirect
Sold at will
$4.75M 475,000 at 10.01
2.5%
Not planned
6 Feb 2026
DeLuca Richard R. EVP&Pres, Merck Animal Heallth
Sold at will
$4.56M 37,685 at 120.92
19.0%
Not planned
6 Feb 2026
MAJORS MICHAEL CLAY EVP - Chief Strategy Officer
Sold at will 4×
$4.41M 30,000 at 146.89
38.9%
Not planned
6 Feb 2026
Fassino Anthony D. Group President
Sold at will
$4.36M 6,033 at 722.15
12.8%
Not planned
6 Feb 2026
Weatherholt Scott C EVP, GC & CCO
Sold at will 2×
$3.99M 37,825 at 105.49
22.6%
Not planned
6 Feb 2026
Kyle Richard G Director
Sold at will
$3.22M 30,206 at 106.52
11.3%
Not planned
6 Feb 2026
OLIVO MARIA EVP, ERM & Chief Risk Officer
Sold at will
$3.13M 10,400 at 300.75
8.1%
Not planned
6 Feb 2026
Mat Ishbia President and CEO · indirect
Sold on a plan
$3.06M 632,874 at 4.84
12.8%
Planned (10b5-1)
6 Feb 2026
Klein Michael Frederick EVP & President, Personal Ins.
Sold at will
$3.01M 10,000 at 301.18
22.9%
Not planned
6 Feb 2026
Horowitz Fran Chief Executive Officer
Sold at will
$2.98M 29,769 at 100.00
8.8%
Not planned
6 Feb 2026
HERSCHER PENNY Director
Sold at will
$2.60M 4,849 at 535.48
44.5%
Not planned
Showing 33,601–33,650 of 46,134. ← Newer Page 673 of 923 Older →